145 related articles for article (PubMed ID: 7288483)
1. The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication.
Waxman A; Ramanna L; Chapman N; Chapman D; Brachman M; Tanasescu D; Berman D; Catz B; Braunstein G
J Nucl Med; 1981 Oct; 22(10):861-5. PubMed ID: 7288483
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose iodine-131 ablation of post-operative thyroid remnants: a study of 69 cases.
Leung SF; Law MW; Ho SK
Br J Radiol; 1992 Oct; 65(778):905-9. PubMed ID: 1422665
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Ramanna L; Waxman AD; Brachman MB; Tanasescu DE; Sensel N; Braunstein GD
Clin Nucl Med; 1985 Nov; 10(11):791-5. PubMed ID: 4075672
[TBL] [Abstract][Full Text] [Related]
4. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer.
Shankar LK; Yamamoto AJ; Alavi A; Mandel SJ
J Nucl Med; 2002 Jan; 43(1):72-6. PubMed ID: 11801706
[TBL] [Abstract][Full Text] [Related]
6. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
Ramanna L; Waxman A; Braunstein G
J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
[TBL] [Abstract][Full Text] [Related]
7. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
[TBL] [Abstract][Full Text] [Related]
8. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
[TBL] [Abstract][Full Text] [Related]
9. Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
Cholewinski SP; Yoo KS; Klieger PS; O'Mara RE
J Nucl Med; 2000 Jul; 41(7):1198-202. PubMed ID: 10914909
[TBL] [Abstract][Full Text] [Related]
10. [Intraoperative localization measurement following preoperative radioiodine marking to facilitate the treatment of differentiated thyroid carcinoma].
Littmann K; Magdsick G; Strötges MW; Eigler FW
Chirurg; 1980 Jun; 51(6):389-94. PubMed ID: 7449540
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
[TBL] [Abstract][Full Text] [Related]
12. Spurious metastasis on whole body scans in a patient with thyroid carcinoma.
Bajramovic S; DeGroot LJ
J Endocrinol Invest; 1998 Sep; 21(8):541-3. PubMed ID: 9801997
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
Bal CS; Kumar A; Pant GS
J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
[TBL] [Abstract][Full Text] [Related]
14. I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours.
Gerard SK; Cavalieri RR
Clin Nucl Med; 2002 Jan; 27(1):1-8. PubMed ID: 11805475
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid carcinoma in children (author's transl)].
Joppich I; Röher HD; Hecker WC; Knorr D; Daum R
Klin Padiatr; 1980 Sep; 192(5):436-9. PubMed ID: 7192339
[TBL] [Abstract][Full Text] [Related]
18. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.
Beierwaltes WH; Nishiyama RH; Thompson NW; Copp JE; Kubo A
J Nucl Med; 1982 Jul; 23(7):561-8. PubMed ID: 7086528
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoma of the thyroid in childhood].
Sgro M; Spreafico GL; Colombo L; Musazzi R
Minerva Chir; 1979 Jan 15-31; 34(1-2):63-72. PubMed ID: 481764
[No Abstract] [Full Text] [Related]
20. Frequency of hepatic visualization during I-131 imaging for metastatic thyroid carcinoma.
Rosenbaum RC; Johnston GS; Valente WA
Clin Nucl Med; 1988 Sep; 13(9):657-60. PubMed ID: 3180614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
